bioClarity, a San Diego, CA-based digitally native, direct-to-consumer skincare brand, raised $13m in the first closing of a new investment round.
The round was led by Prolog Ventures, which invested $6m, with participation other investors.
The company intends to use the funds to accelerate its growth through larger marketing initiatives and additional product innovation.
Led by Rick Sliter, president and CEO, bioClarity skincare routines, face masques, a serum, body wash and beauty supplement. All of bioClarity’s products contain wholesome ingredients such as the brand’s patented Floralux®, a deeply nourishing form of chlorophyll that’s both an antioxidant and clinically proven to help reduce the appearance of redness and pore size. Additionally, the products are vegan, cruelty-free and made without parabens, sulfates and phthalates.
Part of Adigica Health, Inc., the company was founded in 2016.